Navigation Links
Burnham researchers present at 100th AACR Meeting
Date:4/17/2009

LA JOLLA, Calif., April 17, 2009 -- Burnham Institute for Medical Research (Burnham) is pleased to announce that five of its postdoctoral fellows will present seven papers on their data at the American Association for Cancer Research (AACR) 100th Annual Meeting 2009. In addition, John C. Reed, M.D., Ph.D., Burnham President and CEO, Professor and Donald Bren Presidential Chair, will chair a panel on Apoptosis-based Strategies for Cancer Therapy, where he will also present his own research.

This year's meeting, being held in Denver from April 18 to 22, will highlight the best cancer science and medicine from institutions all over the world. In addition to Dr. Reed, Burnham researchers presenting at the AACR meeting include:

  • Lilach Agemy, Ph.D., who will present Nanoparticle-induced Vascular Blockade in Prostate Cancer.
  • Jason Garrison, Ph.D., who will discuss ARTS and Siah Collaborate in a Novel Pathway for XIAP Degradation
  • Shi Ranxin, Ph.D., who will present two papers: Cyclosporin A Sensitizes Cancer Cells to Death Receptor-Mediated Apoptosis and Chemical Biology Strategy Reveals Pathway-Selective Inhibitor of NFκB Activation Induced by Protein Kinase C and Antigen Receptors.
  • Changming Fang, Ph.D., who will also present two papers: Ileal Bile Acid Binding Protein Mediates the Chemopreventative Effect of Ursodeoxycholic Acid by Activating Nuclear Receptor FXRα in Colorectal Cancer and Genetic Deletion of FXRα Promotes Colon Tumorigenesis in ApcMin/+ Mice
  • Adam Richardson, Ph.D., will present The Role of Pentose Phosphate Pathway in the Warburg Effect.


'/>"/>

Contact: Josh Baxt
jbaxt@burnham.org
858-795-5236
Burnham Institute
Source:Eurekalert

Page: 1

Related biology news :

1. The Burnham Buzz, February 2009
2. Burnham researchers discover on switch for cell death signaling mechanism
3. The Burnham buzz
4. Burnham researchers turn cancer friend into cancer foe
5. Burnham researcher awarded $8 million grant
6. Yale researchers uncover secrets of salmonellas stealth attack
7. Singapore researchers first to transform carbon dioxide into methanol
8. Researchers identify specific lung cancer susceptibility gene
9. CSHL researchers explain process by which cells hide potentially dangerous DNA segments
10. Stem cell therapy makes cloudy corneas clear, according to Pitt researchers
11. Biomedical researchers invited to design experiments for the International Space Station
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2016)... --  The Weather Company , an IBM Business (NYSE: ... in which consumers will be able to interact with IBM ... voice or text and receive relevant information about the product ... have long sought an advertising solution that can create a ... and valuable; and can scale across millions of interactions and ...
(Date:6/1/2016)... , June 1, 2016 ... in Election Administration and Criminal Identification to Boost Global ... a recently released TechSci Research report, " Global Biometrics ... Region, Competition Forecast and Opportunities, 2011 - 2021", the ... billion by 2021, on account of growing security concerns ...
(Date:5/20/2016)...  VoiceIt is excited to announce its new ... By working together, VoiceIt and VoicePass will offer ... take slightly different approaches to voice biometrics, collaboration ... usability. Both ... "This marketing and technology partnership allows ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT ... Ontario biotechnology company, Propellon Therapeutics ... development and commercialization of a portfolio of first-in-class ... Epigenetic targets such as WDR5 represent an exciting ... significantly in precision medicine for cancer patients. Substantial ...
(Date:6/23/2016)... -- The Biodesign Challenge (BDC), a university competition that asks ... systems and biotechnology, announced its winning teams at the ... York City . The teams, chosen ... MoMA,s Celeste Bartos Theater during the daylong summit. Keynote ... of architecture and design, and Suzanne Lee , ...
(Date:6/23/2016)... , June 23, 2016 Apellis Pharmaceuticals, ... 1 clinical trials of its complement C3 inhibitor, ... and multiple ascending dose studies designed to assess ... of subcutaneous injection in healthy adult volunteers. ... either as a single dose (ranging from 45 ...
(Date:6/23/2016)... ... June 23, 2016 , ... Regulatory Compliance Associates® ... provides a free webinar on Performing Quality Investigations: Getting to Root ... CT at no charge. , Incomplete investigations are still a major concern to ...
Breaking Biology Technology: